Alpha Cognition Inc. (ACOGF)
USD 5.73
(N/A%)
USD 5.73
(N/A%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 9.7 Million USD | -27.92% |
| 2022 | 13.46 Million USD | 16.4% |
| 2021 | 11.56 Million USD | 102.78% |
| 2020 | 5.7 Million USD | 4.31% |
| 2019 | 5.46 Million USD | 16751.18% |
| 2018 | 32.45 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 2.09 Million USD | -45.14% |
| 2024 Q1 | 4.41 Million USD | 102.87% |
| 2023 Q1 | 1.97 Million USD | -41.47% |
| 2023 FY | 9.85 Million USD | -26.84% |
| 2023 Q2 | 2.71 Million USD | 37.17% |
| 2023 Q4 | 2.17 Million USD | -21.01% |
| 2023 Q3 | 2.75 Million USD | 1.57% |
| 2022 Q2 | 4.37 Million USD | 50.74% |
| 2022 Q1 | 2.9 Million USD | -31.09% |
| 2022 Q4 | 3.37 Million USD | 20.27% |
| 2022 FY | 13.46 Million USD | 16.4% |
| 2022 Q3 | 2.8 Million USD | -35.83% |
| 2021 FY | 11.56 Million USD | 102.78% |
| 2021 Q2 | 2.19 Million USD | 7.72% |
| 2021 Q1 | 2.03 Million USD | 1537.98% |
| 2021 Q4 | 4.21 Million USD | 36.67% |
| 2021 Q3 | 3.08 Million USD | 40.3% |
| 2020 Q4 | 124.53 Thousand CAD | 195.96% |
| 2020 Q3 | 42.07 Thousand USD | 0.0% |
| 2020 FY | 5.7 Million USD | 4.31% |
| 2019 Q4 | 8968.73 CAD | -30.49% |
| 2019 FY | 5.46 Million USD | 16751.18% |
| 2019 Q3 | 12.9 Thousand USD | 0.0% |
| 2018 FY | 32.45 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | 1.33 Million USD | -626.777% |
| Arch Therapeutics, Inc. | 5.04 Million USD | -92.493% |
| Evofem Biosciences, Inc. | 29.55 Million USD | 67.159% |
| Nascent Biotech, Inc. | 2.22 Million USD | -335.252% |
| Rebus Holdings, Inc. | 664 Thousand USD | -1361.687% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | 73.949% |
| Qrons Inc. | 643.67 Thousand USD | -1407.837% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -2391.388% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | 83.103% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -2236.003% |
| Skye Bioscience, Inc. | 13.54 Million USD | 28.359% |
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | 88.816% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | -97.352% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -3608.306% |
| SQZ Biotechnologies Company | 85.61 Million USD | 88.664% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | -232.813% |
| Propanc Biopharma, Inc. | 1.5 Million USD | -546.222% |
| Mesoblast Limited | 5.9 Million USD | -64.446% |
| Marizyme, Inc. | 19.23 Million USD | 49.555% |
| Genus plc | 147.7 Million USD | 93.429% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | -10.552% |
| Pharming Group N.V. | 225.49 Million USD | 95.696% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | -373.743% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -623.464% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | -16.388% |
| ContraFect Corporation | 56.88 Million USD | 82.939% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | -120.148% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | -556.337% |
| IMV Inc. | 37.7 Million USD | 74.262% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | -247.826% |
| MultiCell Technologies, Inc. | 567.42 USD | -1710379.186% |
| ONE Bio Corp. | 6.44 Million USD | -50.617% |
| Accustem Sciences Inc. | 3.74 Million USD | -159.063% |
| RVL Pharmaceuticals plc | 85.94 Million USD | 88.707% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 531.96 Thousand USD | -1724.491% |
| Q BioMed Inc. | 3.43 Million USD | -182.416% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | 60.73% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | -269.382% |
| Biomind Labs Inc. | 994.18 Thousand USD | -876.24% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | 90.229% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | -451.556% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | -44.471% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | -420.583% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 38922.404% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | 39.379% |
| Curative Biotechnology, Inc. | 1.83 Million USD | -428.888% |
| GB Sciences, Inc. | 1.42 Million USD | -583.248% |
| HST Global, Inc. | 140.9 Thousand USD | -6787.948% |
| CSL Limited | 3.44 Billion USD | 99.719% |
| Wesana Health Holdings Inc. | 1.12 Million USD | -762.789% |
| Halberd Corporation | 74.84 Thousand USD | -12868.121% |
| Enzolytics Inc. | 2.17 Million USD | -345.312% |
| Agentix Corp. | 1.37 Million USD | -607.531% |
| Resverlogix Corp. | 12.71 Million USD | 23.65% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | -165.855% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.53 Billion USD | 99.367% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | -829.655% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | -303.57% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | -514.529% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | -185.041% |
| AVAX Technologies, Inc. | 7.31 Million USD | -32.767% |
| Zenith Capital Corp. | 8.94 Million USD | -8.527% |
| Genscript Biotech Corporation | 825.34 Million USD | 98.824% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -55612.077% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | -295.289% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -5558.946% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | -405.262% |
| Kadimastem Ltd | 2.41 Million USD | -302.703% |
| Helix BioMedix, Inc. | 1.97 Million USD | -392.162% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 10.86 Million USD | 10.687% |
| BioStem Technologies, Inc. | 22.97 Million USD | 57.755% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -5247.881% |
| LadRx Corporation | 3.81 Million USD | -154.62% |
| Cell Source, Inc. | 4.32 Million USD | -124.389% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -950.947% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | -950.947% |
| NovAccess Global Inc. | 2.46 Million USD | -293.455% |
| Affymax, Inc. | 39.38 Million USD | 75.358% |
| Itoco Inc. | 919.14 Thousand USD | -955.94% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | -128.991% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | -767.346% |
| Mobile Lads Corp. | 554.54 Thousand USD | -1650.189% |
| CytoDyn Inc. | 18.05 Million USD | 46.253% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -38461.727% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -4310.073% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | -583.593% |
| SYBLEU INC | 160.87 Thousand USD | -5932.97% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | -434.355% |
| International Stem Cell Corporation | 5.27 Million USD | -84.132% |
| Bioxytran, Inc. | 3.82 Million USD | -154.064% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -18336.991% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -47609.782% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | 73.238% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | -499.852% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | -1218.991% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | -211.977% |
| Neutra Corp. | 243.82 Thousand USD | -3880.626% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | 44.403% |
| PureTech Health plc | 144.59 Million USD | 93.288% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | 52.632% |
| IXICO plc | 4.7 Million USD | -106.195% |
| IntelGenx Technologies Corp. | 8.79 Million USD | -10.329% |
| Gelesis Holdings, Inc. | 117.74 Million USD | 91.757% |
| CSL Limited | 3.89 Billion USD | 99.751% |
| Cellectis S.A. | 97.32 Million USD | 90.027% |